期刊文献+

老年慢性心力衰竭的多病因性及心衰类型分析 被引量:1

The analysis of the multifactor and type of heart failure in the elderly
下载PDF
导出
摘要 目的对老年心力衰竭的多病因性及心衰类型、程度进行分析,对临床诊治提高参考。方法将206例老年心衰患者根据不同年龄段分为(60~69)岁、(70~79)岁和≥80岁三个年龄段,分析病因构成特点与心衰类型,并根据超声心动图对E/A,EF,LVD进行临床分析。结果老年心衰患者中94.7%为多病因,基础疾病以冠心病、高血压、肺心病为主,合并疾病以COPD、糖尿病、心律失常为主。老年人心力衰竭主要以舒张性心衰为主,占66.99%。结论老年心力衰竭患者主要以舒张性心衰为主,在治疗上应考虑到心衰的多病因性,进行防治。 Objective To evaluate the multifactor,the type and degree of chronic heart failure in elderly patients and to provide a reference for prevention and treatment of heart failure. Methods 206 elderly patients hospitalized for heart failure were included. The patients were divided into three groups:60-69 years old,70-79 years old and ≥80 years old group,to analysis the multifactor,the type of CHF,E/A,EF and LVD. Results The patients with muhifactors account for 94.7% of the heart failure in the elderly. The most number of basic disease in muhifaetor are the coronary heart disease, hypertension and corpulmonale. The most number of accompany disease are the COPD ,diabetes and arrhythmia. The type of heart failure in the elderly is dominated by diastolic heart failure ,occupy 66.99%. Conclusions The type of heart failure in the elderly is dominated by diastolic heart failure. So we must considered the muhifaetor when treating and preventing.
出处 《中国老年保健医学》 2009年第4期108-110,共3页 Chinese Journal of Geriatric Care
关键词 心力衰竭 多病因 老年人 舒张性心力衰竭 Heart failure,multifactor,Aged,diastolie heart failure
  • 相关文献

参考文献2

二级参考文献12

  • 1Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
  • 2Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
  • 3Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
  • 4Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
  • 5Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
  • 6Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
  • 7Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
  • 8Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
  • 9Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.
  • 10The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomised trial. Lancet, 1999,353:9-13.

共引文献219

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部